Rationale: Evidence suggests that the gut microbiome is involved in the development of
cardiovascular disease, with the host–microbe interaction regulating immune and metabolic …

Atrial fibrillation (AF) is of public health importance and profoundly increases morbidity,
mortality, and healthrelated expenditures. Morbidities include the increased risks of …

Aims: Oral bacteria have been reported to be associated with the pathogenesis of
atherosclerosis; however, the relationship between the oral microbiota and atherosclerosis …

Aims Preliminary evidence from animal and human studies shows that gut microbiota
composition and levels of microbiota-derived metabolites, including short-chain fatty acids …

Ecological relationships between bacteria are important when considering variation in
bacterial communities in humans, with such variation playing an important role in both …

Background Accumulating evidence has suggested that gut microbiota dysbiosis is
commonly observed in asthmatics. However, it remains unclear whether dysbiosis is a …

Objective: Gut microbiota is a newly identified risk factor for stroke, and there are no large
prospective studies linking the baseline gut microbiome to long-term risk of stroke. We …

Animal models support a role for the gut microbiota in the development of hypertension.
There has been a lack of epidemiological cohort studies to confirm these findings in human …

Human gut microbiota produce a variety of molecules, some of which enter the bloodstream
and impact health. Conversely, dietary or pharmacological compounds may affect the …

Background The gut bacteria-derived metabolite trimethylamine-N-oxide (TMAO) has been
discussed in various cardiometabolic diseases. However, evidence characterizing the …